English   español  

Browsing by Author Ocaña, Alberto

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 126  next >
RightsPreviewIssue DateTitleAuthor(s)Type
openAccessTranscriptomic_Pérez_Peña_Art2019.pdf.jpg18-Dec-2019A Transcriptomic Immunologic Signature Predicts Favorable Outcome in Neoadjuvant Chemotherapy Treated Triple Negative Breast TumorsPérez-Peña, Javier; Tibor Fekete, Janos; Páez, Raquel; Baliu-Piqué, Mariona; García-Saenz, José Ángel; García-Barberán, Vanesa; Manzano, Aranzazu CSIC ORCID ; Pérez-Segura, Pedro; Esparís-Ogando, Azucena CSIC ORCID ; Pandiella, Atanasio CSIC ORCID CVN ; Győrffy, Balázs; Ocaña, Albertoartículo
openAccessMeta-Analysis.pdf.jpg2014Activation of the PI3K/mTOR/AKT pathway and survival in solid tumors: systematic review and meta-analysisOcaña, Alberto; Cuenca-López, María D.; Seruga, Bostjan; Pandiella, Atanasio CSIC ORCID CVN ; Amir, Eitanartículo
closedAccessaccesoRestringido.pdf.jpg2012Active kinase profiling, genetic and pharmacological data define mTOR as an important common target in triple-negative breast cancerMontero, Juan Carlos CSIC ORCID; Esparís-Ogando, Azucena CSIC ORCID ; Re-Louhau, M. F. CSIC; Seoane, Samuel CSIC ORCID; Abad, María del Mar; Calero, R.; Ocaña, Alberto; Pandiella, Atanasio CSIC ORCID CVN artículo
openAccessactivity_BET-proteolysis_targeting_chimeric.pdf.jpg30-Aug-2019Activity of BET-proteolysis targeting chimeric (PROTAC) compounds in triple negative breast cancerNoblejas-López, María del Mar; Nieto-Jiménez, Cristina; Burgos, Miguel; Gómez-Juárez, Mónica; Montero, Juan Carlos CSIC ORCID; Esparís-Ogando, Azucena CSIC ORCID ; Pandiella, Atanasio CSIC ORCID CVN ; Galán-Moya, Eva María; Ocaña, Albertoartículo
closedAccessaccesoRestringido.pdf.jpg2020Adaptive resistance to trastuzumab impairs response to neratinib and lapatinib through deregulation of cell death mechanismsRíos-Luci, Carla; Díaz-Rodríguez, Elena CSIC ORCID CVN; Gandullo-Sánchez, Lucía CSIC ORCID; Díaz-Gil, Laura CSIC; Ocaña, Alberto; Pandiella, Atanasio CSIC ORCID CVN artículo
openAccess13046_2022_2330_MOESM1_ESM.pdf.jpg23-Mar-2022Additional file 1 of Surfaceome analyses uncover CD98hc as an antibody drug-conjugate target in triple negative breast cancer [Dataset]Montero, Juan Carlos CSIC ORCID; Calvo-Jiménez, Elisa; Carmen, Sofía del; Abad, María del Mar; Ocaña, Alberto; Pandiella, Atanasio CSIC ORCID CVN dataset
openAccess23-Mar-2022Additional file 2 of Surfaceome analyses uncover CD98hc as an antibody drug-conjugate target in triple negative breast cancer [Dataset]Montero, Juan Carlos CSIC ORCID; Calvo-Jiménez, Elisa; Carmen, Sofía del; Abad, María del Mar; Ocaña, Alberto; Pandiella, Atanasio CSIC ORCID CVN dataset
openAccess23-Mar-2022Additional file 3 of Surfaceome analyses uncover CD98hc as an antibody drug-conjugate target in triple negative breast cancer [Dataset]Montero, Juan Carlos CSIC ORCID; Calvo-Jiménez, Elisa; Carmen, Sofía del; Abad, María del Mar; Ocaña, Alberto; Pandiella, Atanasio CSIC ORCID CVN dataset
openAccessAdoptive_Fuentes_Art2020.pdf.jpgOct-2020Adoptive Cell Therapy in Breast Cancer: A Current Perspective of Next-Generation MedicineFuentes-Antrás, Jesús; Guevara-Hoyer, Kissy; Baliu-Piqué, Mariona; García-Saenz, José Ángel; Pérez-Segura, Pedro; Pandiella, Atanasio CSIC ORCID CVN ; Ocaña, Albertoartículo de revisión
closedAccessaccesoRestringido.pdf.jpg17-May-2018Alteraciones transcripcionales en la vía de la ubiquitina-proteasoma (UPP) de células HER2+ resistentes a trastuzumabOrive-Ramos, Ana CSIC; Pérez-Peña, Javier; Ocaña, Alberto; Pandiella, Atanasio CSIC ORCID CVN comunicación de congreso
openAccessAltered proTGFα_García Alonso_PV_Art2021.pdf.jpg2021Altered proTGFα/cleaved TGFα ratios offer new therapeutic strategies in renal carcinomaGarcía-Alonso, Sara; Romero-Pérez, Inés; Gandullo-Sánchez, Lucía CSIC ORCID; Chinchilla, Luis; Ocaña, Alberto; Montero, Juan Carlos CSIC ORCID; Pandiella, Atanasio CSIC ORCID CVN artículo
openAccessOverview_Juan_PV_Art2020.pdf.jpg2020An Overview of Antibody Conjugated Polymeric Nanoparticles for Breast Cancer TherapyJuan, Alberto; Cimas, Francisco J.; Bravo, Iván; Pandiella, Atanasio CSIC ORCID CVN ; Ocaña, Alberto; Alonso-Moreno, Carlosartículo
openAccessAntibody_Juan_PV_Art2020.pdf.jpg21-Aug-2020Antibody Conjugation of Nanoparticles as Therapeutics for Breast Cancer TreatmentJuan, Alberto; Cimas, Francisco J.; Bravo, Iván; Pandiella, Atanasio CSIC ORCID CVN ; Ocaña, Alberto; Alonso, Carlos CSICartículo
openAccessEC-70124.pdf.jpg2015Antitumor activity of the novel multi-kinase inhibitor EC-70124 in triple negative breast cancerCuenca-López, María D.; Serrano-Heras, Gemma CSIC ORCID; Montero, Juan Carlos CSIC ORCID; Morales, Jorge C.; Pandiella, Atanasio CSIC ORCID CVN ; Ocaña, Albertoartículo
openAccessAntitumoral Activity of a CDK9_Noblejas_PV_Art2022.pdf.jpg2022Antitumoral activity of a CDK9 PROTAC compound in HER2-Positive breast cancerNoblejas-López, María del Mar; Gandullo-Sánchez, Lucía CSIC ORCID; Galán-Moya, Eva María; López-Rosa, Raquel; Tebar-García, David; Nieto-Jiménez, Cristina; Gómez-Juárez, Mónica; Burgos, Miguel; Pandiella, Atanasio CSIC ORCID CVN ; Ocaña, Albertoartículo
openAccessarrest in G2.pdf.jpg2015Antitumoral activity of the mithralog EC-8042 in triple negative breast cancer linked to cell cycle arrest in G2Pandiella, Atanasio CSIC ORCID CVN ; Morís, Francisco; Ocaña, Alberto; Núñez, Luz-Elena; Montero, Juan Carlos CSIC ORCIDartículo
openAccessBETcan.pdf.jpg2017BET inhibitors as novel therapeutic agents in breast cancerOcaña, Alberto; Nieto-Jiménez, Cristina; Pandiella, Atanasio CSIC ORCID CVN artículo
closedAccessaccesoRestringido.pdf.jpg2014Biological insights into effective and antagonistic combinations of targeted agents with chemotherapy in solid tumorsOcaña, Alberto; Freedman, Orit; Amir, Eitan; Seruga, Bostjan; Pandiella, Atanasio CSIC ORCID CVN artículo
closedAccessaccesoRestringido.pdf.jpg2016Breast cancer dissemination promoted by a neuregulin-collagenase 3 signalling nodeSeoane, Samuel CSIC ORCID; Montero, Juan Carlos CSIC ORCID; Ocaña, Alberto; Pandiella, Atanasio CSIC ORCID CVN artículo
openAccessBreast_Baliu_PV_Art2020.pdf.jpg2020Breast Cancer Heterogeneity and Response to Novel TherapeuticsBaliu-Piqué, Mariona; Pandiella, Atanasio CSIC ORCID CVN ; Ocaña, Albertoartículo